GDC-0810
- Generic Name
- GDC-0810
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H20ClFN2O2
- CAS Number
- 1365888-06-7
- Unique Ingredient Identifier
- 9MM2R1A06R
- Background
ARN-810 has been used in trials studying the basic science and treatment of Breast Cancer.
- Associated Conditions
- -
- Associated Therapies
- -
Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential
- First Posted Date
- 2015-12-04
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT02621957
A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy
- First Posted Date
- 2015-10-07
- Last Posted Date
- 2021-04-23
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 71
- Registration Number
- NCT02569801
- Locations
- 🇺🇸
Florida Cancer Specialists-Broadway, Fort Myers, Fort Myers, Florida, United States
🇺🇸Florida Cancer Specialists (St. Petersburg - St. Anthony's Professional Building), Saint Petersburg, Florida, United States
🇺🇸The Center for Cancer and Blood Disorders - Fort Worth, Fort Worth, Texas, United States
A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-04-04
- Last Posted Date
- 2021-06-18
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 152
- Registration Number
- NCT01823835
- Locations
- 🇳🇱
VU MEDISCH CENTRUM; Dept. of Medical Oncology, Amsterdam, Netherlands
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath